Home › Core › ISCC-IDs › 28CrYcVJxzY6X

View ISCC-ID

Core Data

28CrYcVJxzY6X
ISCC-ID - digital asset identifier
CCL7QkxQDyKkP-CTEahM1BAfR5h-CDWdvyUaxZStd-CR1eZfp9LTKy9
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

263 antibioticfree production of a herpes simplex virus 2 dna vaccine in a high yield cgmp process

Ledger Reference

coblo
Source Ledger/Blockchain
379369
N-th ISCC Decleration on source ledger
2942e8fbad326684613bf969962c8e98ac9e1f9451b79d86ec3525613d4815e4
Hash of block that includes the ISCC-DECLARATION
430d003792a63e85b59f5e6643840180387e7c77b7bff8f61bbd04eb1f23f373
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "263. Antibiotic-Free Production of a Herpes Simplex Virus 2 DNA Vaccine in a High Yield cGMP Process", "@type": "ScholarlyArticle", "genre": "journal-article", "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3906406?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/s1525-0016(16)34598-1", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCL7QkxQDyKkP-CTEahM1BAfR5h-CDWdvyUaxZStd-CR1eZfp9LTKy9", "propertyID": "ISCC"}], "datePublished": "2013-05-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close